Part 2: MetaInsight COVID-19 - A feasibility study

Rapid evidence synthesis for COVID-19 International GuidanceПодробнее

Minton Road Feasibility Study Virtual Public Meeting #2Подробнее

Part 3: Limitations and future plansПодробнее

Evolving Understanding on COVID-19 Vaccines and SARS-CoV-2 VariantsПодробнее

Long Covid: Research, Policy & Economic Impact Conference Session 2 — Industry-Specific ImplicationsПодробнее

Supporting the evidence synthesis response to the COVID-19 pandemic – the COVID-END networkПодробнее

Webinar: Responding to Emerging SARS CoV 2 VariantsПодробнее

Part 2: Demonstration of MetaInsightПодробнее

Viral Genomics in Terra - COVID Module Tutorial | Part 2Подробнее

Gut microbiota composition is associated with SARS-CoV-2 vaccine immunogenicityПодробнее

Building a metadata model for COVID-19: Interview with Anna BernasconiПодробнее

Getting from Data to Analysis and Insight in the Covid-19 Pandemic [Webinar]Подробнее

Covid-19: How to manage the next wave of disruption? Input from Risk Managers & McKinsey ExpertsПодробнее

Evidence to Policy: the HIQA experience of evidence synthesis during the COVID-19 pandemicПодробнее

Dr. Natalie Prystajecky: Sequencing of SARS-CoV-2 as a tool for pandemic responseПодробнее

MIT A+B 2019-253-idea generation and feasibility assessment for new co2 direct airПодробнее

Revolutionizing healthcare through AI | Life Science Report 2025Подробнее

Involvement in COVID-19 rapid evidence synthesis: training & supporting patient/public partnersПодробнее

Webinar: Responding to the COVID-19 Pandemic - Clinical Laboratories PerspectivesПодробнее